Your password must be at least 8 characters and contain a number and letter.
Donor-Derived Cell-Free DNA in D-OAR, a Real World, Clinical Use Heart Transplant PopulationJon Kobashigawa, MD
Donor-Specific Antibodies in Heart Transplantation: Do Clinicians Need to do Something Always?Yasbanoo Moayedi, MD
The Evolving (In)significance of Panel Reactive Antibody on Cardiac Transplantation Outcomes in the Modern EraJennifer Chung, MD
Development of Rejection Risk Prediction Model by Routine Monitoring for De-novo Donor Specific Antibodies After Heart TransplantationKa Lam Wong, MBBS
Patients Bridged to Transplant with Durable LVAD Support Have a Higher Risk of Post-Transplant De Novo Donor Specific AntibodiesRobert Cole, MD
It’s HLA-DR Not HLA-DQ Donor-specific Antibody That is Correlated to CAV After Heart TransplantMichael Olymbios, MD
You must be logged in and own this session in order to